Ally Bridge Group (Ny) LLC Applied Therapeutics Inc. Transaction History
Ally Bridge Group (Ny) LLC
- $141 Million
- Q3 2024
A detailed history of Ally Bridge Group (Ny) LLC transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Ally Bridge Group (Ny) LLC holds 618,332 shares of APLT stock, worth $544,132. This represents 3.73% of its overall portfolio holdings.
Number of Shares
618,332Holding current value
$544,132% of portfolio
3.73%Shares
1 transactions
Others Institutions Holding APLT
# of Institutions
140Shares Held
112MCall Options Held
1.68MPut Options Held
1.91M-
Janus Henderson Group PLC London, X010.5MShares$9.28 Million0.05% of portfolio
-
Morgan Stanley New York, NY9.9MShares$8.72 Million0.01% of portfolio
-
Vr Adviser, LLC New York, NY9.83MShares$8.65 Million8.65% of portfolio
-
Perceptive Advisors LLC New York, NY8.01MShares$7.04 Million1.78% of portfolio
-
Franklin Resources Inc San Mateo, CA6.8MShares$5.98 Million0.02% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $42.3M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...